Informations sur le stock Roche | Filter Basic-Info
Action: Roche (Suisse large), ISIN: CH0012032048
| Last price | 352.70 | Cours maximal | 374.00 |
| Cours minimal | 258.90 | Retour sur 1 année | 19.27 |
| Objectif moyen | 334.89 | Retour attendu | -5.05 % |
| Secteur | Services de Santé | Sous-secteur | Pharmacie |
| Vendre | 1 | Notations |
|
| Retenu | 4 | Consensus |
  
|
| Acheter | 4 | ||
| Rapport annuels 2015 |
Loading...
Contact info:Street: 1 DNA WayZip Code: South San City: BASEL,Country: SwitzerlandPhone: 1 650 225 5566Email: RocheIRNA@gene.comWebsite: www.roche.comCEO: Dr Severin SchwanCFO: Dr. Alan Hippe
Sector Review Roche
Loading...
| Année | Chiffre d'affaires | Total du secteur | Part de marché |
|---|---|---|---|
| 2019 | 56,656 | 474,848 | 11.93 % |
| 2020 | 53,954 | 469,560 | 11.49 % |
| 2021 | 60,561 | 566,739 | 10.69 % |
| 2022 | 63,966 | 640,095 | 9.99 % |
| 2023 | 63,226 | 590,728 | 10.70 % |
Advice Roche
News Roche
Roche Teams Up with Zealand Pharma in $5.3 Billion Push Toward Obesity Breakthrough
Swiss healthcare leader Roche has entered a strategic alliance with Danish biotech innovator Zealand Pharma , committing up to $5.3 billion to co-develop and bring to market a new obesity therapy known as petrelintide. Deal Structure and Funding: Zealand...
2008 best year, 2009 worst year for Roche
Roche-investors have very profitable for long times. Even without dividend payments the stock is one of the outperformers from as well pharmaceutical sector as the Swiss exchange. The received dividends are a cherry on the cake for investors. The matrix above...
Roche inks potential $3B multi-target strategic collaboration with Shape Therapeutics
Roche (OTCQX:RHHBY) has signed a multi-target strategic collaboration and license agreement with Shape Therapeutics.
Under the terms of the agreement, Shape is eligible to receive an initial payment as well as development, regulatory and sales milestone...
Analysts expect over 2020 rising revenue Roche
For this year Roche's revenue will be around 61,6 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue of 61,47 billion CHF. Historical revenues and results Roche plus estimates 2020 SKF The analysts...
Analysts expect revenue increase Roche
Tomorrow the Swiss Roche will report its past quarters results. Over the current book year the total revenue will be 62,25 billion CHF (consensus estimates). This is slightly more than 2018's revenue of 56,85 billion CHF. Historical revenues and results Roche...
Annual reports Roche
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile Roche
No Records Found
Results Roche
| Résultats |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenu |
|
|
|
|
|
| Coûts |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Marge de profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
Balance Roche
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
Details Roche
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
232.60
|
246.50
|
243.40
|
314.00
|
309.00
|
| Eps |
10.41
|
8.59
|
10.85
|
14.40
|
15.29
|
| Price/earnings-ratio |
22.34
|
28.70
|
22.43
|
21.81
|
23.07
|
| Dividend |
7.66
|
7.10
|
7.73
|
8.30
|
8.42
|
| Dividend % |
3.29 %
|
2.88 %
|
3.18 %
|
2.64 %
|
2.39 %
|
| Payout % |
0.74
|
0.83
|
0.71
|
0.58
|
0.55
|
| Book value |
32.30
|
32.60
|
35.34
|
43.38
|
48.50
|
| Market to book |
0.14
|
0.13
|
0.15
|
0.14
|
0.14
|
| Cashflow per stock |
20.26
|
22.23
|
25.56
|
29.66
|
24.78
|
| Stocks |
692
|
694
|
694
|
696
|
693
|
| Market Cap |
160.942.37
|
171.033.96
|
169.023.78
|
218.467.38
|
244.465.54
|
Dividend Roche
Price info Roche
|
Date
|
Price
|
|---|---|
|
09 Oct 2026
|
352.70
|
|
08 Oct 2026
|
360.00
|
|
06 Oct 2026
|
348.90
|
|
17 Sep 2026
|
362.50
|
|
15 Sep 2026
|
361.40
|
|
14 Sep 2026
|
344.20
|
|
28 Aug 2026
|
364.00
|
|
11 Aug 2026
|
373.10
|
|
07 Aug 2026
|
364.70
|
|
06 Aug 2026
|
364.70
|
|
28 Jul 2026
|
360.10
|
|
14 Jul 2026
|
330.70
|
|
10 Jul 2026
|
336.60
|
|
09 Jul 2026
|
335.50
|
|
08 Jul 2026
|
334.90
|
|
07 Jul 2026
|
339.50
|
|
06 Jul 2026
|
331.80
|
|
03 Jul 2026
|
340.60
|
|
02 Jul 2026
|
341.50
|
|
01 Jul 2026
|
328.80
|
|
30 Jun 2026
|
332.80
|
|
29 Jun 2026
|
338.80
|
|
26 Jun 2026
|
336.00
|
|
25 Jun 2026
|
335.30
|
|
24 Jun 2026
|
332.00
|
|
23 Jun 2026
|
325.20
|
|
22 Jun 2026
|
318.60
|
|
19 Jun 2026
|
319.80
|
|
18 Jun 2026
|
319.00
|
|
17 Jun 2026
|
327.80
|
